Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Condition: Cancer of the Head and Neck Interventions: Drug: INCAGN01876; Drug: INCMGA00012; Biological: DPV-001 Sponsor: Providence Health & Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials